Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy

NeuroReport

Volumn 9, Issue 8, 1998, Pages 1757-1761

  Kalra, Sanjay ^a   Cashman, Neil R ^a   Genge, Angela ^a   Arnold, Douglas L ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Amyotrophic lateral sclerosis; Magnetic resonance spectroscopy; N acetylaspartate; Riluzole

Indexed keywords

CREATINE; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; N ACETYLASPARTIC ACID; RILUZOLE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; MALE; MOTONEURON; MOTOR CORTEX; NERVE CELL LESION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORAL DRUG ADMINISTRATION; PATIENT MONITORING; PRIORITY JOURNAL; SURVIVAL RATE; TRACHEOSTOMY;

EID: 0032102114     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199806010-00016     Document Type: Article

References (29)

1. Rosen DR, Siddique T, Patterson D et al. Nature 362, 59-62 (1993).
2. Rothstein JD. Adv Neurol 63, 7-20 (1995).
3. Rothstein JD, Dykes-Hoberg M, Pardo CA et al. Neuron 16, 675-686 (1996).
4. Bensimon G, Locomblez L, Meininger V et al. New Engl J Med 330, 585-591 (1994).
5. Lacomblez L, Bensimon G, Leigh PN et al. Lancet 347, 1425-1431 (1996).
6. Doble A. Neurology 47 (Suppl. 4), 233-241 (1996).
7. Koller KJ, Zaczek R and Coyle JT. J Neurochem 43, 1136-1142 (1984).
8. Simmons ML, Frondoza CG and Coyle JT. Neuroscience 45, 37-45 (1991).
9. Moffett JR, Namboodiri MA, Cangro CB and Neale JH. NeuroReport 2, 131-134 (1991).
10. Pioro EP, Antel JP, Cashman NR and Arnold DI. Neurology 44, 1933-1938 (1994).
11. Kalra S, Genge A, Cashman N et al. Neurology 48 (Suppl. 2), 129 (1997).
12. Brooks BR. J Neurol Sci 124(Suppl.), 96-107 (1994).
13. Bruhn H, Frahm J, Gyngell ML et al. Magn Reson Med 9, 126-131 (1989).
14. Menon DK, Baudouin CJ, Tomlinson D and Hoyle C. J Comp Assis Tomogr 14, 882-885 (1990).
15. Mattthews PM, Andermann F, Silver K et al. Neurology 43, 2484-2490 (1993).
16. Arnold DL and Matthews PM. Practical aspects of clinical applications of MRS in the brain. In Young IR and Charles HC, eds. MR Spectroscopy: Clinical Applications and Techniques. London: Martin Dunitz Publishers, 1995: 139-159.
17. Davie CA, Barker GJ, Webb S et al. Brain 118, 1583-1592 (1995).
18. De Stefano N, Matthews PM and Arnold DL. Magn Reson Med 34, 721-727 (1995).
19. Arnold DL, Matthews PM and De Stefano N. MRI and proton MRS in the evaluation of multiple sclerosis. In: Bachelard, ed. Advances in Neurochemistry. New York: Plenum Press, 1997: 267-288.
20. Cendes F, Andermann F, Dubeau F et al. Neurology 49, 1525-1533 (1997).
21. Uno M, Ueda S, Hondo H et al. Neurol Med-Chir 36, 560-566 (1996).
22. Vion-Dury J, Nicoli F, Salvan AM et al. Lancet 345, 60-61 (1995).
23. Karpati G, Carpenter S and Durham H. Rev Neurol 144, 672-675 (1988).
24. Schinder AF, Olson EC, Spitzer NC and Montal M. J Neurosci 16, 6125-6133 (1996).
25. White RJ and Reynolds IJ. J Neurosci 16, 5688-5697 (1996).
26. Budd SL and Nicholls DG. J Neurochem 67, 2282-2291 (1996).
27. Truckenmiller ME, Namboodiri MA, Brownstein MJ and Neale JH. J Neurochem 45, 1658-1662 (1985).
28. Bates TE, Strangward M, Keelan J et al. NeuroReport 7, 1397-1400 (1996).
29. Matthews PM, Cianfaglia L, MCLaurin J et al. Proc Soc Magn Reson Eur Soc Magn Reson Med Biol 1, 147 (1995).